DIAGNOS Inc. (OTCMKTS:DGNOF – Get Free Report) was the recipient of a significant growth in short interest during the month of August. As of August 31st, there was short interest totaling 10 shares, a growth of ∞ from the August 15th total of 0 shares. Based on an average daily trading volume, of 167,416 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s shares are sold short.
DIAGNOS Stock Down 6.2%
DGNOF opened at $0.33 on Thursday. The company has a market cap of $40.91 million, a P/E ratio of -8.34 and a beta of 0.01. The business’s 50-day moving average price is $0.26 and its 200-day moving average price is $0.20. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.33. DIAGNOS has a 12 month low of $0.13 and a 12 month high of $0.38.
DIAGNOS Company Profile
DIAGNOS Inc is a Canadian healthcare technology company focused on the early detection of medical conditions through artificial intelligence, image processing and telemedicine. The company develops and commercializes tools designed to help healthcare providers identify disease at an earlier stage and support access to diagnostic services.
Its principal platform, CARA (Computer Assisted Retinal Analysis), analyzes retinal images to assist with the screening of conditions such as diabetic retinopathy and other eye diseases.
Featured Stories
- Five stocks we like better than DIAGNOS
- Analysts See Double-Digit Upside for These 3 Stocks
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.
